CELU celularity.com: Forvard P/S multiplikatori
Celularity Inc. rahbariyati hozirda o'zining hujayraviy platformasini biomateriallarning to'liq miqyosdagi tijoratlashtirilishi va monetizatsiyasi uchun moslashtirmoqda. Ishlab chiqarish barqarorligi New Jersey shtatidagi qat'iy steril nazoratga ega bo'lgan maxsus zavodlar va kriomaxzanlar orqali ta'minlanadi. Yo'ldoshga asoslangan to'qimalarni regeneratsiya qilish texnologiyasi narxlarni belgilash imkoniyatini yaratadi. Forward P/S tendentsiyasi bozor kutganlarini aks ettiradi, bunda 1.10 eng so'nggi metrika ko'rsatkichini ifodalaydi.
celularity.com (CELU) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Celularity Inc.|CELU - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Celularity|CELU - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Celularity Inc.|CELU - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Celularity|Tezkor likvidlik koeffitsiyenti celularity.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
CELU - Sof moliyaviy natija|Kelajakdagi foyda Celularity Inc.|CELU - Bozor narxining sof foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Celularity|CELU - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Celularity Inc.|CELU - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Celularity|CELU - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi celularity.com|CELU - Bu yil bir aksiya uchun foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Celularity Inc.
- tushum va sotuvlar tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:Celularity Corp CELU
Celularity Inc. (CELU) kompaniyasining biznes barqarorligi platsenta terapiyasining tijoratlashtirilishi va regenerativ tibbiyot uchun biomateriallar sotuviga bog'liq. Bashorat qilingan P/S dinamikasi kompaniyaning joriy bozor qiymatini kutilayotgan daromadlar bilan bog'laydi va bunda foiz stavkalarining kapital qiymatiga ta'siri hisobga olinadi. Ushbu koeffitsiyentning oshishi bozor kutuvlarining ortiqchaligidan dalolat beradi, bu esa narxning adolatli qiymat darajasigacha korreksiyasi xavfini oshiradi.
Celularity Inc. raqobatchilari
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA Corp (ADMA) - Forvard narx/daromad multiplikatori|PTGX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati immunovant.com (IMVT)|Narxning prognoz qilingan daromadga nisbati Kiniksa|Narxning prognoz qilingan daromadga nisbati GRFS|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|Forvard P/S multiplikatori Celldex Corp (CLDX)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|biocryst.com - Narxning prognoz qilingan daromadga nisbati|Vera Therapeutics - Forvard P/S multiplikatori|DNTH - Forvard P/S multiplikatori|Pharvaris Corp (PHVS) - Narxning prognoz qilingan daromadga nisbati|AbCellera Corp - Sotuvga nisbatan forvard narx|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|precigen.com (PGEN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PHAR (Pharming Group)|Narxning kutilayotgan daromadga nisbati NKTR|Upstream Bio Corp - Forvard narx/daromad multiplikatori|Zenas Corp (ZBIO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|IMNM: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx GOSS (gossamerbio.com)|KALV: Forvard P/S multiplikatori|SEPN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals Inc|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SVRA (Savara Pharma)|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori anaptysbio.com ANAB|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc (ENGN)|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|Aerovate Therapeutics Inc (JBIO) - Forvard narx/daromad multiplikatori|ACRS: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati kyvernatx.com (KYTX)|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences Ltd|Narxning prognoz qilingan daromadga nisbati CABA|Forvard narx/daromad multiplikatori VTYX (Ventyx Bio)|Forvard P/S multiplikatori Theratechnologies, Inc (THTX)|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|ELDN (eledon.com) - Kelajakdagi narxning daromadga nisbati|Agenus Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx CLYM (Climb Bio Inc.)|ZURA: Forvard P/S multiplikatori|aTyr Pharmaceuticals (ATYR) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Adagene Inc|IMA: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Shattuck Labs, Inc. (STTK)|Forvard narx/daromad multiplikatori equilliumbio.com EQ|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx IFRX (InflaRx N.V.)|XFOR: Forvard P/S multiplikatori|ACET - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati INmune Bio Corp|Forvard narx/daromad multiplikatori Barinthus Biotherapeutics Corp (BRNS)|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|Forvard narx/daromad multiplikatori sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning prognoz qilingan daromadga nisbati|GOVX (GeoVax Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|EDSA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati ibioinc.com (IBIO)|CARM (Carisma Therapeutics Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori XTL Biopharmaceuticals Ltd (XTLB)|Forvard P/S multiplikatori BOLT|HCWB - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. - Narxning prognoz qilingan daromadga nisbati|ADTX: Forvard narx/daromad multiplikatori|GRI - Forvard P/S multiplikatori|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|HIND (Vyome Therapeutics) - Narxning prognoz qilingan daromadga nisbati|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Forvard P/S multiplikatori indaptusrx.com|Narxning prognoz qilingan daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|CALI (calcimedica.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Allakos Inc (ALLK)|HOOK: Forvard narx/daromad multiplikatori|IGM Biosciences, Inc. - Narxning kutilayotgan daromadga nisbati|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ocean Biomedical Inc (OCEA)|Forvard narx/daromad multiplikatori TCBP|THRD: Sotuvga nisbatan forvard narx
